Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

393 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.
Nuermberger E, Grosset J. Nuermberger E, et al. Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):243-55. doi: 10.1007/s10096-004-1109-5. Epub 2004 Mar 13. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15024625 Review.
Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
Craft JC, Notario GF, Grosset JH, Heifets LB. Craft JC, et al. Clin Infect Dis. 1998 Oct;27(4):807-12. doi: 10.1086/514961. Clin Infect Dis. 1998. PMID: 9798037 Clinical Trial.
New drugs for the treatment of tuberculosis: hope and reality.
Grosset JH, Singer TG, Bishai WR. Grosset JH, et al. Int J Tuberc Lung Dis. 2012 Aug;16(8):1005-14. doi: 10.5588/ijtld.12.0277. Int J Tuberc Lung Dis. 2012. PMID: 22762423 Review.
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
Williams KN, Stover CK, Zhu T, Tasneen R, Tyagi S, Grosset JH, Nuermberger E. Williams KN, et al. Antimicrob Agents Chemother. 2009 Apr;53(4):1314-9. doi: 10.1128/AAC.01182-08. Epub 2008 Dec 15. Antimicrob Agents Chemother. 2009. PMID: 19075058 Free PMC article.
Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection.
Zhang T, Li SY, Converse PJ, Grosset JH, Nuermberger EL. Zhang T, et al. PLoS Negl Trop Dis. 2013 Dec 19;7(12):e2598. doi: 10.1371/journal.pntd.0002598. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24367713 Free PMC article.
Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.
Grosset JH, Tyagi S, Almeida DV, Converse PJ, Li SY, Ammerman NC, Bishai WR, Enarson D, Trébucq A. Grosset JH, et al. Am J Respir Crit Care Med. 2013 Sep 1;188(5):608-12. doi: 10.1164/rccm.201304-0753OC. Am J Respir Crit Care Med. 2013. PMID: 23822735 Free PMC article.
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Zhang T, Bishai WR, Grosset JH, Nuermberger EL. Zhang T, et al. Antimicrob Agents Chemother. 2010 Jul;54(7):2806-13. doi: 10.1128/AAC.00400-10. Epub 2010 Apr 26. Antimicrob Agents Chemother. 2010. PMID: 20421401 Free PMC article.
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
Nuermberger E, Tyagi S, Tasneen R, Williams KN, Almeida D, Rosenthal I, Grosset JH. Nuermberger E, et al. Antimicrob Agents Chemother. 2008 Apr;52(4):1522-4. doi: 10.1128/AAC.00074-08. Epub 2008 Feb 19. Antimicrob Agents Chemother. 2008. PMID: 18285479 Free PMC article.
Impacts of interleukin-12 on multiplication of Mycobacterium tuberculosis and Mycobacterium avium complex in mice.
Lounis N, Ji B, Truffot-Pernot C, Ridley RG, Alber G, Grosset JH. Lounis N, et al. Clin Microbiol Infect. 1999 Jun;5(6):331-338. doi: 10.1111/j.1469-0691.1999.tb00152.x. Clin Microbiol Infect. 1999. PMID: 11856278
393 results
Jump to page
Feedback